LifeStance Health Group Announces Launch Of Secondary Public Offering

Certain LifeStance Health stockholders intend to sell 22.25 million common shares through a registered secondary offering under an SEC shelf registration statement. The transaction could create near-term share-price overhang from increased tradable supply, though it does not represent new equity issuance by the company.